Loading...

Bio-Gene Technology Limited

BGT.AXASX
Healthcare
Biotechnology
A$0.02
A$0.00(0.00%)

Bio-Gene Technology Limited (BGT.AX) Company Profile & Overview

Explore Bio-Gene Technology Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Bio-Gene Technology Limited (BGT.AX) Company Profile & Overview

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

SectorHealthcare
IndustryBiotechnology
CEOTimothy Owen Grogan LLB

Contact Information

61 3 9068 1062
456 Lonsdale Street, Melbourne, VIC, 3000

Company Facts

IPO DateNov 28, 2017
CountryAU
Actively Trading

Frequently Asked Questions

;